{
    "N/R/U": null,
    "Applicant": "Ferring Pharmaceuticals Inc.",
    "BLA Number": "125739",
    "Proprietary Name": "Rebyota",
    "Proper Name": "fecal microbiota, live-jslm",
    "BLA Type": "351(a)",
    "Strength": "BETWEEN 1X10^8 AND 5X10^10CFU",
    "Dosage Form": "Suspension",
    "Route of Administration": "Rectal",
    "Product Presentation": "Single-Use Bottle",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "November 30, 2022",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "2112",
    "Product Number": "001",
    "Center": "CBER",
    "Date of First Licensure": "November 30, 2022",
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": "November 30, 2034",
    "Orphan Exclusivity Exp. Date": "November 30, 2029",
    "drug": [
        {
            "name": "fecal microbiota, live-jslm",
            "drugbank_id": "https://go.drugbank.com/drugs/DB17743"
        }
    ]
}